Ketamine clinical trials at University of California Health
4 in progress, 1 open to eligible people
Low-Dose Intravenous Ketamine for Adolescents With Depression and Suicidal Ideation in the Emergency Department
open to eligible people ages 12-18
The goal of this study is to test whether a single low-dose of IV ketamine given in the emergency department to adolescents with treatment-resistant depression and suicidal ideation can reduce depression symptoms and suicidal thoughts compared to placebo. Participants will complete depression scales at baseline, and 1 hour, 3 hours, 1 day, 3 days, and 7 days after receiving the treatment.
at UCSD
Pragmatic Trial of Psilocybin Therapy in Palliative Care
Sorry, not yet accepting patients
This multicenter, triple-blind, phase 2, randomized controlled trial will evaluate the efficacy and safety of psilocybin therapy compared to an active control in treating demoralization in adults near the end of life (≤2 years life expectancy).
at UCLA UCSF
Anesthetics and Analgesics in Children
Sorry, not currently recruiting here
The purpose of this study is to characterize the pharmacokinetic (PK) and safety profile of anesthetics and analgesics in children and adolescents.
at UCSF
Prospective Study of Induction Medications Used in the Trauma RSI
Sorry, not yet accepting patients
To compare the outcomes of the use of propofol, etomidate, and ketamine as induction agents for adult trauma patients undergoing intubation within 24 hours of admission. The primary goal is to determine the ideal agent that should be used in this patient population for intubations.
at UC Irvine
Our lead scientists for Ketamine research studies include Charles S. Grob, M.D..
Last updated: